Breaking News Instant updates and real-time market news.

INCY

Incyte

$63.56

0.11 (0.17%)

, UMRX

Unum Therapeutics

$4.46

0.07 (1.59%)

07:06
01/03/19
01/03
07:06
01/03/19
07:06

Incyte appoints Christiana Stamoulis as CFO

Incyte (INCY) announced the appointment of Christiana Stamoulis as Executive Vice President and CFO, effective February 11. Stamoulis will succeed David Gryska who, as planned, retired from Incyte at the end of 2018. She joins Incyte from Unum Therapeutics (UMRX), where she was President and CFO.

INCY

Incyte

$63.56

0.11 (0.17%)

UMRX

Unum Therapeutics

$4.46

0.07 (1.59%)

  • 03

    Jan

  • 24

    May

INCY Incyte
$63.56

0.11 (0.17%)

10/30/18
PIPR
10/30/18
NO CHANGE
Target $85
PIPR
Overweight
Incyte Q3 'not great,' but valuation 'very reasonable,' says Piper Jaffray
Although inventory destocking contributed to the Jakafi sales miss in Q3, it is never comforting to see a growth franchise report numbers that are essentially flat quarter-over-quarter, Piper Jaffray analyst Tyler Van Buren tells investors in a post-earnings research note titled "Q3 Results Weren't Great, But Larger 2019 Pipeline Readouts Are The Focus". However, the analyst says this negative impact has already reversed heading into Q4. He continues to believe that Incyte shares are trading at a "very reasonable valuation" based solely on the approved, revenue-generating drug franchise. Van Buren remains focused on the company's pipeline readouts in 2019 and reiterates an Overweight rating on the shares with an $85 price target.
10/22/18
RAJA
10/22/18
UPGRADE
RAJA
Strong Buy
Incyte upgraded to Strong Buy from Outperform at Raymond James
01/03/19
GUGG
01/03/19
UPGRADE
GUGG
Buy
Incyte upgraded to Buy from Neutral at Guggenheim
12/02/18
PIPR
12/02/18
NO CHANGE
Target $85
PIPR
Overweight
Initial Incyte PI3Kdelta combo data 'promising,' says Piper Jaffray
Piper Jaffray analyst Tyler Van Buren notes that Incyte presented an update of the Phase II trial evaluating INCB050465 in MF patients who have had suboptimal response to ruxolitinib monotherapy. While the initial data suggest clinical benefit in these patients, the addition of Cohorts 3 and 4 which incorporate continuous dosing of parsaclisib and will likely report in 2019, will be necessary to assess long-term benefit, he contends. Additionally, as many attempt to compare these data to the previously reported umbralisib combo data, the analyst views the differences in patient enrollment criteria between the parsaclisib and umbralisib combination programs as material, and therefore views any comparison as "futile." Van Buren has an Overweight rating and $85 price target on the shares.
UMRX Unum Therapeutics
$4.46

0.07 (1.59%)

04/23/18
COWN
04/23/18
INITIATION
COWN
Market Perform
Unum Therapeutics initiated with a Market Perform at Cowen
Cowen analyst Eric Schmidt started Unum Therapeutics initiated with a Market Perform rating.
04/23/18
04/23/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. OP Bancorp (OPBK) initiated with a Neutral at DA Davidson and a Market Perform at Keefe Bruyette. 2. Homology Medicines (FIXX) initiated with an Outperform at Cowen and Evercore ISI as well as a Buy at BofA/Merrill. 3. GrubHub (GRUB) initiated with a Hold at Gabelli. 4. Unum Therapeutics (UMRX) initiated with an Overweight at Morgan Stanleya, an Outperform at Wedbush, a Buy at SunTrust, and a Market Perform at Cowen. 5. Nautilus (NLS) initiated with a Buy at Craig-Hallum. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
12/20/18
HCWC
12/20/18
INITIATION
Target $18
HCWC
Buy
Unum Therapeutics initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Andrew Fein started Unum Therapeutics with a Buy rating and $18 price target. While most T-cell therapy players are focusing on tackling one or two aspects of the major challenges faced by CAR-T, the differentiating value of Unum resides in its potential to address all aspects especially its unique advantages in targeting solid tumors, where the largest commercial opportunities lie for new entrants in the space, says the analyst.
04/23/18
MSCO
04/23/18
INITIATION
Target $20
MSCO
Overweight
Unum Therapeutics initiated with an Overweight at Morgan Stanley
Morgan Stanley analyst Matthew Harrison started Unum Therapeutics with an Overweight rating and $20 price target, noting that initial data suggests activity in liquid tumors and that the opportunity to differentiate in solid tumors, which is a market that is more than 4 times larger, is the key upside driver with initial data in 2019.

TODAY'S FREE FLY STORIES

TOT

Total

$54.72

-0.08 (-0.15%)

, USO

United States Oil Fund

$11.94

-0.055 (-0.46%)

14:27
11/11/19
11/11
14:27
11/11/19
14:27
Periodicals
Total CEO sees weak oil demand growth next year, Bloomberg says »

Total CEO Patrick…

TOT

Total

$54.72

-0.08 (-0.15%)

USO

United States Oil Fund

$11.94

-0.055 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMB

Kimberly-Clark

$131.12

-0.37 (-0.28%)

, ACN

Accenture

$189.95

0.34 (0.18%)

14:25
11/11/19
11/11
14:25
11/11/19
14:25
Periodicals
Kimberly-Clark moving some ad duties to Accenture from WPP, WSJ says »

Kimberly-Clark (KMB) has…

KMB

Kimberly-Clark

$131.12

-0.37 (-0.28%)

ACN

Accenture

$189.95

0.34 (0.18%)

WPP

WPP

$64.60

-0.01 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

  • 19

    Nov

  • 19

    Dec

  • 23

    Jan

WPP

WPP

$64.60

-0.01 (-0.02%)

, ACN

Accenture

$190.05

0.44 (0.23%)

14:21
11/11/19
11/11
14:21
11/11/19
14:21
Periodicals
Kimberly-Clark moving some ad duties to Accenture from WPP, WSJ says »

Kimberly-Clark (KMB) has…

WPP

WPP

$64.60

-0.01 (-0.02%)

ACN

Accenture

$190.05

0.44 (0.23%)

KMB

Kimberly-Clark

$131.12

-0.37 (-0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

  • 19

    Nov

  • 19

    Dec

  • 23

    Jan

MS

Morgan Stanley

$49.30

0.15 (0.31%)

14:20
11/11/19
11/11
14:20
11/11/19
14:20
Options
Heavy bullish option flow in Morgan Stanley January term »

Heavy bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

  • 12

    Nov

BABA

Alibaba

$186.42

-0.69 (-0.37%)

, AAPL

Apple

$261.99

1.79 (0.69%)

14:17
11/11/19
11/11
14:17
11/11/19
14:17
Hot Stocks
Alibaba reports 11.11 gross merchandise volume grew 26% year-over-year to $38.4B »

Alibaba Group (BABA)…

BABA

Alibaba

$186.42

-0.69 (-0.37%)

AAPL

Apple

$261.99

1.79 (0.69%)

EL

Estee Lauder

$186.46

-0.81 (-0.43%)

GPS

Gap

$17.01

0.32 (1.92%)

LRLCY

L'Oreal

$0.00

(0.00%)

LEVI

Levi Strauss

$17.07

-0.06 (-0.35%)

NSRGY

Nestle

$0.00

(0.00%)

NKE

Nike

$89.89

0.09 (0.10%)

VFC

VF Corp.

$86.52

-0.56 (-0.64%)

UA

Under Armour

$15.81

-0.07 (-0.44%)

UAA

Under Armour

$17.53

-0.02 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 21

    Nov

  • 06

    Feb

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
11/11/19
11/11
14:17
11/11/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
11/11/19
11/11
14:16
11/11/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$6.05

-0.42 (-6.49%)

14:13
11/11/19
11/11
14:13
11/11/19
14:13
Periodicals
CA governor raises objections to $11B PG&E insurance deal, WSJ reports »

California Governor Gavin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 07

    Jan

AUPH

Aurinia Pharmaceuticals

$5.05

-0.085 (-1.66%)

14:05
11/11/19
11/11
14:05
11/11/19
14:05
Options
Aurinia Pharmaceuticals call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

LPCN

Lipocine

$0.78

-1.945 (-71.38%)

14:04
11/11/19
11/11
14:04
11/11/19
14:04
Recommendations
Lipocine analyst commentary  »

Lipocine price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIT

Fitbit

$6.93

-0.13 (-1.84%)

13:55
11/11/19
11/11
13:55
11/11/19
13:55
Options
Fitbit put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$7.61

-0.02 (-0.26%)

13:45
11/11/19
11/11
13:45
11/11/19
13:45
Options
Deutsche Bank call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPCN

Lipocine

$0.82

-1.9039 (-69.87%)

13:37
11/11/19
11/11
13:37
11/11/19
13:37
Downgrade
Lipocine rating change  »

Lipocine downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BABA

Alibaba

$185.80

-1.31 (-0.70%)

13:35
11/11/19
11/11
13:35
11/11/19
13:35
Recommendations
Alibaba analyst commentary  »

Alibaba Singles Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

S

Sprint

$5.89

-0.22 (-3.60%)

13:35
11/11/19
11/11
13:35
11/11/19
13:35
Options
Sprint put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

GOOG

Alphabet

$1,299.39

-9.97 (-0.76%)

, GOOGL

Alphabet Class A

$1,298.40

-9.58 (-0.73%)

13:34
11/11/19
11/11
13:34
11/11/19
13:34
Periodicals
Google gathering health data on millions of Americans, WSJ reports »

Alphabet's (GOOG,…

GOOG

Alphabet

$1,299.39

-9.97 (-0.76%)

GOOGL

Alphabet Class A

$1,298.40

-9.58 (-0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMK

Weis Markets

$39.40

-0.06 (-0.15%)

, VLGEA

Village Super Market

$26.80

-0.38 (-1.40%)

13:31
11/11/19
11/11
13:31
11/11/19
13:31
Periodicals
Amazon to open grocery store alternative to Whole Foods, CNET says »

CNET's Ben Fox Rubin…

WMK

Weis Markets

$39.40

-0.06 (-0.15%)

VLGEA

Village Super Market

$26.80

-0.38 (-1.40%)

WMT

Walmart

$118.86

-0.55 (-0.46%)

SVU

Supervalu

$0.00

(0.00%)

KR

Kroger

$26.51

-0.5 (-1.85%)

CASY

Casey's General Stores

$166.95

0.07 (0.04%)

AMZN

Amazon.com

$1,770.99

-14.36 (-0.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 19

    Nov

  • 20

    Nov

CDE

Coeur Mining

$6.25

0.305 (5.13%)

13:25
11/11/19
11/11
13:25
11/11/19
13:25
Options
Coeur Mining call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WE

We Company

$0.00

(0.00%)

, JLL

Jones Lang LaSalle

$161.83

0.23 (0.14%)

13:21
11/11/19
11/11
13:21
11/11/19
13:21
Periodicals
We Company outsourcing cleaning staff to JLL, Business Insider reports »

We Company (WE) is…

WE

We Company

$0.00

(0.00%)

JLL

Jones Lang LaSalle

$161.83

0.23 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGM

MGM Resorts

$31.41

0.01 (0.03%)

, DSS

Document Security

$0.34

0.0059 (1.76%)

13:18
11/11/19
11/11
13:18
11/11/19
13:18
On The Fly
Fly Insider: MGM, IDEXX Laboratories among week's notable insider trades »

Welcome to "Fly Insider,"…

MGM

MGM Resorts

$31.41

0.01 (0.03%)

DSS

Document Security

$0.34

0.0059 (1.76%)

CNFR

Conifer Holdings

$4.32

0.42 (10.77%)

OFIX

Orthofix

$44.42

-0.46 (-1.03%)

LMNX

Luminex

$19.33

0.96 (5.23%)

UBER

Uber

$26.93

-0.08 (-0.30%)

REPL

Replimune Group

$16.69

-0.11 (-0.65%)

TPX

Tempur Sealy

$86.40

0.82 (0.96%)

IDXX

Idexx Laboratories

$253.71

-0.8 (-0.31%)

BX

Blackstone

$51.89

0.475 (0.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 19

    Nov

  • 21

    Nov

  • 04

    Dec

  • 09

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
11/11/19
11/11
13:17
11/11/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
11/11/19
11/11
13:16
11/11/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,299.68

-9.68 (-0.74%)

, GOOGL

Alphabet Class A

$1,298.85

-9.13 (-0.70%)

13:13
11/11/19
11/11
13:13
11/11/19
13:13
Hot Stocks
Google says 12 games available on Stadia November 19, including 'Red Dead 2' »

In a blog post, Google…

GOOG

Alphabet

$1,299.68

-9.68 (-0.74%)

GOOGL

Alphabet Class A

$1,298.85

-9.13 (-0.70%)

UBSFY

Ubisoft

$0.00

(0.00%)

T

AT&T

$39.29

-0.08 (-0.20%)

TTWO

Take-Two

$118.69

1.85 (1.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

  • 13

    Nov

  • 18

    Nov

  • 19

    Nov

  • 21

    Nov

  • 09

    Dec

  • 09

    Dec

  • 29

    Jan

TSN

Tyson Foods

$82.88

0.305 (0.37%)

, ROK

Rockwell Automation

$179.88

2.13 (1.20%)

13:05
11/11/19
11/11
13:05
11/11/19
13:05
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

TSN

Tyson Foods

$82.88

0.305 (0.37%)

ROK

Rockwell Automation

$179.88

2.13 (1.20%)

DHI

D.R. Horton

$52.12

1.005 (1.97%)

CBS

CBS

$38.77

0.65 (1.71%)

AAP

Advance Auto Parts

$167.74

0.5 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 18

    Nov

  • 19

    Nov

  • 20

    Nov

  • 09

    Dec

TME

Tencent Music

$14.43

0.44 (3.15%)

, DXC

DXC Technology

$29.61

-0.47 (-1.56%)

13:05
11/11/19
11/11
13:05
11/11/19
13:05
Earnings
Notable companies reporting after market close »

Notable companies…

TME

Tencent Music

$14.43

0.44 (3.15%)

DXC

DXC Technology

$29.61

-0.47 (-1.56%)

TERP

TerraForm Power

$16.57

0.07 (0.42%)

FNV

Franco-Nevada

$95.95

0.34 (0.36%)

UGI

UGI Corporation

$46.23

-0.33 (-0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

  • 11

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.